The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
Essential medicines were made available to more than 150 countries around the world during the pandemic
The government has taken all the effective measures to make healthcare affordable
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
India produces 60% of the world’s vaccine
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Dr. Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 2pt February 2021.
Subscribe To Our Newsletter & Stay Updated
